LA
OACC

Linden Advisors’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Linden Advisors’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.43M Hold
600,000
– – 0.03% 274
2026
Q1 		$6.37M Hold
600,000
– – 0.04% 252
2025
Q4 		$6.38M Hold
600,000
– – 0.04% 225
2025
Q3 		$6.28M Hold
600,000
– – 0.04% 200
2025
Q2 		$6.29M Hold
600,000
– – 0.04% 204
2025
Q1 		$6.12M Buy
+600,000
New +$6.02M 0.04% 178

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Linden Advisors's OACC Position: Q2 2026 in Review

Linden Advisors held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 600,000 shares worth $6.43M. The position accounts for 0.03% of the portfolio, ranked #274.

Linden Advisors first reported a position in OACC in Q1 2025 and has held it in 6 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Linden Advisors held 600,000 shares of Oaktree Acquisition Corp III Life Sciences worth $6.43M as of Q2 2026.
  • Linden Advisors left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.03% of Linden Advisors's portfolio in Q2 2026, its #274 holding.
  • Linden Advisors first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Linden Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.